Skip to main content
SpringerLink
Log in

The role of iron and iron binding proteins in lymphocyte physiology and pathology

  • Special Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Knowledge concerning the roles of iron and iron binding proteins in lymphocyte physiology and pathology has developed rapidly over the last few years. The genes for the major iron binding proteins have been cloned and sequenced and are now being studied with respect to transcriptional and posttranscriptional regulatory mechanisms. T cells, B cells, macrophages, and natural killer cells appear to differ from one another in the ways in which they synthesize and utilize iron binding proteins and in the amount of iron they take up and store. This suggests that differential modulation of iron-dependent metabolic functions is an intrinsic part of the distinctive physiology of each cellular component of the immune system and that the distribution of iron between those components is a carefully managed facet of the immune response. Since the immune response does not seem to be dramatically impaired by alterations in iron supplies that adversely affect other organs, it may well be that the cells of the immune system are especially adapted to have both high-priority access to iron when supply is low and high-level protection against iron-related toxicity when supply is in excess.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pietrangelo A, Rocchi E, Casalgrandi G, Rigo G, Ferrari A, Perini M, Ventura E, Cairo G: Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum. Gastroenterology 102(3):1071–1073, 1992

    Google Scholar 

  2. Lombard M, Bomford AB, Polson RJ, Bellingham AJ, Williams R: Differential expression of transferrin receptor in duodenal mucosa in iron overload. Evidence for a site-specific defect in genetic hemochromatosis. Gastroenterology 98(4):976–984, 1990

    Google Scholar 

  3. Chasteen ND: The identification of the probable locus of iron and anion binding in the transferrins. Trends Biochem Sci 8:272–275, 1983

    Google Scholar 

  4. Young SP, Bomford AB, Williams R: The effect of the iron saturation of transferrin on its binding and uptake by rabbit reticulocytes. Biochem J 219:505–510, 1984

    Google Scholar 

  5. Jing S, Trowbridge IA: Identification of the intermolecular disulphide bonds of the human transferrin receptor and its lipid-attachment site. EMBO J 6:327–331, 1987

    Google Scholar 

  6. Trowbridge IS, Newman RA, Domingo DL, Sauvage C: Transferrin receptors: Structure and function. Biochem Pharmacol 33(6):925–932, 1984

    Google Scholar 

  7. Do SI, Enns C, Cummings RD: Human transferrin receptor contains O-linked oligosaccharides. J Biol Chem 265(1):114–125, 1990

    Google Scholar 

  8. Trowbridge IA, Collawn J, Shuqian Jing, White S, Esekogwu V, Stangel M. Structure-function analysis of the human transferrin receptor: Effects of antireceptor monoclonal antibodies on tumor growth. In Biotechnology of Plasma Proteins. Curr Stud Hematol Blood Transf, A Albertini, CL Lenfant, PM Mannucci, JJ Sixma (eds). Basel, Karger, 1991, Vol 58, pp 139–147, 1991

    Google Scholar 

  9. Morgan EH, Baker E: Role of transferrin receptors and endocytosis in iron uptake by hepatic and erythroid cells. Ann NY Acad Sci 526:65–82, 1988

    Google Scholar 

  10. Dautry-Varsat A, Ciechanover A, Lodish HF: pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci USA 80:2258–2262, 1983

    Google Scholar 

  11. Nilsen T, Romslo I: Subcellular localization of transferrin and pyrophosphate in liver cells after perfusionin situ or incubationin vitro. Scand J Clin Lab Invest 52(5):373–378, 1992

    Google Scholar 

  12. Reichard P, Ehrenberg A: Ribonucleotide reductase—A radical enzyme. Science 221:514–519, 1983

    Google Scholar 

  13. Thelander L, Gräslund A, Thelander M: Continual presence of oxygen and iron required for mammalian ribonucleotide reduction: Possible regulation mechanism. Biochem Biophys Res Comm 110(3):859–865, 1983

    Google Scholar 

  14. Wharton M, Granger DL, Durack DT: Mitochondrial iron loss from leukemia cells injuryed by macrophages. J Immunol 141:1311–1317, 1988

    Google Scholar 

  15. Nelson MJ, Batt DG, Thompson JS, Wright SW: Reduction of the active-site iron by potent inhibitors of lipoxygenases. J Biol Chem 266(13):8225–8229, 1991

    Google Scholar 

  16. Bomford AB, Munro HN: Ferritin gene expression in health and malignancy. Pathology 60:10–18, 1992

    Google Scholar 

  17. Arosio P, Levi S, Santambrogio P, Cozzi A, Luzzago A, Cesareni G, Albertini A: Structural and functional studies of human ferritin H and L chains. In Biotechnology of Plasma Proteins. Curr Stud Hematol Blood Transf, A Albertini, CL Lenfant, PM Mannucci, JJ Sixma (eds). Basel, Karger, 1991, Vol 58, pp 127–131

    Google Scholar 

  18. Ford GC, Harrison PM, Rice DW, Smith JMA, Treffry A, White JL, Yariv J: Ferritin: Design and function of an iron-storage molecule. Phil Trans R Soc Lond B304:551–565, 1984

    Google Scholar 

  19. Fargion S, Fracanzani AL, Cislaghi V, Levi S, Cappellini MD, Fiorelli G: Characteristics of the membrane receptor for human H-ferritin. In Biotechnology of Plasma Proteins. Curr Stud Hematol Blood Transf, A Albertini, CL Lenfant, PM Mannucci, JJ Sixma (eds). Basel, Karger, 1991, Vol. 58, pp 164–170

    Google Scholar 

  20. Klausner RD, Harford JB: Cis-trans models for posttranscriptional gene regulation. Science 246:870–872, 1989

    Google Scholar 

  21. Haile DJ, Rouault TA, Tang CK, Chin J, Harford JB, Klausner RD: Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: Role of the iron-sulfur cluster. Proc Natl Acad Sci USA 89(16):7536–7540, 1992

    Google Scholar 

  22. Masson PL, Heremans JF, Schonne E: Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 130:643, 1969

    Google Scholar 

  23. Broxmeyer HE, Mantel C, Gentile P, Srivastave C, Miyazawa K, Zucali JR, Rado TA, Levi S, Arosio P: Actions of H-subunit ferritin and lactoferrin as suppressor molecules of myelopoiesisin vitro andin vivo. In Biotechnology of Plasma Proteins. Curr Stud Hematol Blood Transf, A Albertini, CL Lenfant, PM Mannucci, JJ Sixma (eds). Basel, Karger, 1991, Vol 58, pp 178–181

    Google Scholar 

  24. Brown JP, Hewick RW, Hellstrom I, Hellstrom KE, Doolittle RF, Dreyer WJ: Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature 296:171–173, 1982

    Google Scholar 

  25. Brown JP, Woodbury RG, Hart CE, Hellström I, Hellström KE: Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci USA 78(1):539–543, 1981

    Google Scholar 

  26. Jensen C, Burgart L, Stewart B, Naumann P, Kemp J: Melanotransferrin (p97): Flow cytometric studies of expression and regulation in B lymphoblastoid cell lines and immunohistochemical studies of expression in brain vasculature. Lab Invest 66(1):107A, 1922

  27. Garratt RC, Jhoti H: A molecular model for the tumour-associated antigen, p97, suggests a Zn-binding function. FEBS Lett 305(1):55–61, 1992

    Google Scholar 

  28. Krönke M, Leonard WJ, Depper JM, Greene WC: Sequential expression of genes involved in human T lymphocyte growth and differentiation. J Exp Med 161:1593–1598, 1985

    Google Scholar 

  29. Weiel JE, Hamilton TA: Quiescent lymphocytes express intracellular transferrin receptors. Biochem Biophys Res Comm 119(2):598–602, 1984

    Google Scholar 

  30. Neckers LM, Cossman J: Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. Proc Natl Acad Sci USA 80:3494, 1983

    Google Scholar 

  31. Kumagai N, Benedict SH, Mills GB, Gelfand EW: Comparison of phorbol ester/calcium ionophore and phytohe-magglutinin-induced signaling in human T lymphocytes. J Immunol 140(1):37–43, 1988

    Google Scholar 

  32. Quyand Q, Miskimins WK: A supercoil-dependent structural alteration within the regulatory region of the human transferrin receptor gene. Biochem Biophys Res Comm 183(1):62–69, 1992

    Google Scholar 

  33. Pelosi-Testa E, Samoggia P, Giannella G, Montesoro E, Caravita T, Salvo G, Camagna A, Isacchi G, Tests U, Peschle C: Mechanisms underlying T-lymphocyte activation: Mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level. Immunology 64:273–279, 1988

    Google Scholar 

  34. Lum JB, Infante AJ, Makker DM, Yang F, Bowman BH: Transferrin synthesis by inducer T lymphocytes. J Clin Invest 77:841–849, 1986

    Google Scholar 

  35. Thorson JA, Smith KM, Gomez F, Naumann PW, Kemp JD: Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine. Cell Immunol 134(1):126–137, 1991

    Google Scholar 

  36. Kemp JD, Thorson JA, Gomez F, Smith KM, Cowdery JS, Ballas ZK: Inhibition of lymphocyte activation with anti-transferrin receptor Mabs: A comparison of three reagents and further studies of their range of effects and mechanism of action. Cell Immunol 122(1):218–230, 1989

    Google Scholar 

  37. Weber RJ, Finkelman FD: Increased expression of the B lymphocyte receptor for transferrin is stimulated byin vivo cross-linking of cell surface IgD. Cell Immunol 104:400, 1987

    Google Scholar 

  38. Futran J, Kemp JD, Field EH, Vora A, Ashman RF: Transferrin receptor synthesis is an early event in B cell activation. J Immunol 143:787–792, 1989

    Google Scholar 

  39. Neckers LM, Yenokida G, James SP: The role of the transferrin receptor in human B lymphocyte activation. J Immunol 133:2437, 1984

    Google Scholar 

  40. Thorson JA: Iron, Transferrin, and the Transferrin Receptor in Lymphocyte Growth: Studies with an Anti-Transferrin Receptor Monoclonal Antibody, Doctoral thesis, Department of Microbiology, University of Iowa, 1992

  41. Lederman HM, Cohen A, Lee JWW, Freedman MH, Gelfand EW: Deferoxamine: A reversible S-phase inhibitor of human lymphocyte proliferation. Blood 64:748, 1984

    Google Scholar 

  42. Hirata T, Bitterman PB, Mornex JF, Crystal RG: Expression of the transferrin receptor gene during the process of mononuclear phagocyte maturation. J Immunol 136(4):1339–1345, 1986

    Google Scholar 

  43. Testa U, Petrini M, Quarnata MT, Pelosi-Testa E, Mastroberardino G, Camagna A, Boccoli G, Sargiacomo M, Isacchi G, Cozzi A, Arosio P, Peschle C: Iron upmodulates the expression of transferrin receptors during monocyte-macrophage maturation. J Biol Chem 264:13181–13187, 1989

    Google Scholar 

  44. Testa U, Petrini M, Quaranta MT, Pelosi E, Kühn L, Peschle C: Differential regulation of iron-responsive element-binding protein in activated lymphocytes versus monocytes-macrophages. In Biotechnology of Plasma Proteins. Curr Stud Hematol Blood Transf, A Albertini, CL Lenfant, PM Mannucci, JJ Sixma (eds). Basel, Karger, 1991, Vol 58, pp 158–163

    Google Scholar 

  45. Wei Y, Miller SC, Tsuji Y, Torti SV, Torti FM: Interleukin 1 induces ferritin heavy chain in human muscle cells. Biochem Biophys Res Comm 169(1):289–296, 1990

    Google Scholar 

  46. Alvarez-Hernández X, Licéaga J, McKay IC, Brock JH: Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 61(3):319–322, 1989

    Google Scholar 

  47. Reif DW, Simmons RD: Nitric oxide mediates iron release from ferritin. Arch Biochem Biophys 283(2):537–541, 1990

    Google Scholar 

  48. London L, Perussia B, Trinchieri G: Induction of proliferationin vitro of resting human natural killer cells: Expression of surface activation antigens. J Immunol 134(2):718–727, 1985

    Google Scholar 

  49. Vodinelich L, Sutherland R, Schneider C, Newman R, Greaves M: Receptor for transferrin may be a “target” structure for natural killer cells. Immunology 80:835–839, 1983

    Google Scholar 

  50. Baines MG, Lafleur FL, Holbein BE: Involvement of transferrin and transferrin receptors in human natural killer effector: target interaction. Immunol Lett 7:51–55, 1983

    Google Scholar 

  51. Newman RA, Warner JF, Dennert G: NK recognition of target structures: Is the transferrin receptor the NK target structure? J Immunol 133(4):1841–1845, 1984

    Google Scholar 

  52. Lopez-Guerrero JA, Redondo JM, Alarcon B, Sanchez-Madrid F, Rodriguez-Moya M, Ortiz-de-Landazuri M, Bernabeu C, Fresno M: Different functional domains on the transferrin receptor molecule defined by monoclonal antibodies. Immunology 66(2):252–257, 1989

    Google Scholar 

  53. Dokhélar MC, Garson D, Testa U, Tursz T: Target structure for natural killer cells: Evidence against a unique role for transferrin receptor. Eur J Immunol 14:340–344, 1984

    Google Scholar 

  54. Benoist H, Comoe L, Joly P, Carpentier Y, Desplaces A Dufer J: Comparative effect of fagaronine, adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis. Lack of agreement between alteration of transferrin receptor and CD15 antigen expressions and induction of resistance to natural killer. Cancer Immunol Immunother 30(5):289–294, 1989

    Google Scholar 

  55. Bridges KR, Smith BR: Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells. J Clin Invest 76(3):913–918, 1985

    Google Scholar 

  56. Salmon M, Bacon PA, Young SP: Natural killer cells in peripheral blood and the mixed lymphocyte response: Interaction with the transferrin receptor. Immunology 62(1):81–87, 1987

    Google Scholar 

  57. Perl A, Looney RJ, Ryan DH, Abraham GN: The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cell sensitive for natural killing. J Immunol 136(12):4714–4720, 1986

    Google Scholar 

  58. Storkus WJ, Dawson JR: B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation. J Immunol 136(5):1542–1547, 1986

    Google Scholar 

  59. Rieber EP, Rank G, Riethmuller G: Transferrin receptors on tumor and bone marrow cells: Lack of involvement as target structure for natural killer cells. Kin Wochenschr 31(21):1119–1123, 1986

    Google Scholar 

  60. Borysiewicz LK, Graham S, Sissons JG: Human natural killer cell lysis of virus-infected cells. Relationship to expression of the transferrin receptor. Eur J Immunol 16(4):405–411, 1986

    Google Scholar 

  61. Tazzari PL, Zauli D, Raspadori D, Crespi C, Magnani M, Tassinari A, Gobbi M: Role of target and effector cell structures in natural killer-mediated cytotoxicity. Ric Clin Lab 16(3):443–447, 1986

    Google Scholar 

  62. Joynson DHM, Jacob A, Walker DM, Dalby AE: Defect of cell-mediated immunity in patients with iron-deficiency anaemia. Lancet 2:1058, 1972

    Google Scholar 

  63. MacDougall LG, Anderson R, McNab GM, Katz J: The immune response in iron deficient children: Impaired cellular defense mechanisms with altered humoral components. J Pediat 86:833, 1975

    Google Scholar 

  64. Bhaskaram P, Reddy V: Cell-mediated immunity in iron and vitamin deficient children. Br Med J 3:522, 1975

    Google Scholar 

  65. Chandra RK, Saraya AK: Impaired immuno-competence associated with iron deficiency. J Pediat 86:899–901, 1975

    Google Scholar 

  66. Fletcher J, Mather J, Lewis MJ, Withing G: Mouth lesions in iron-deficient anemia: Relationship to Candida albicans in saliva and to impairment of lymphocyte transformation. J Infect Dis 131:44–50, 1975

    Google Scholar 

  67. Krantman HJ, Yound SR, Ank BJ, O'Donnel MC, Rachelefsky GS, Stiehman RE: Immune function in pure iron deficiency. Am J Dis Child 136:840–844, 1982

    Google Scholar 

  68. Sawitsky B, Knater R, Sawitsky A: Lymphocyte response to phytomitogens in iron deficiency. Am J Med Sci 277:153–160, 1976

    Google Scholar 

  69. Galan P, Thibault H, Preziosi P, Hercberg S: Interleukin 2 production in iron-deficient children. Biol Trace Elem Res 32:421–426, 1992

    Google Scholar 

  70. Kuvibidila S, Dardenne M, Savino W, Lepault F: Influence of iron-deficiency anemia on selected thymus functions in mice: Thymulin biological activity, T-cell subsets, and thymocyte proliferation. Am J Clin Nutr 51:228–232, 1990

    Google Scholar 

  71. Kuvibidila SR, Baliga BS, Suskind RM: Effects of iron deficiency anemia on delayed cutaneous hypersensitivity in mice. Am J Clin Nutr 34:2635–2640, 1981

    Google Scholar 

  72. Baliga BS, Kuvibidila SR, Susking RM: Effect of iron deficiency on the cell mediated immune response. Ind J Pediat 49:431–445, 1982

    Google Scholar 

  73. Kuvibidila SR, Baliga BS, Suskind RM: Generation of plaque forming cells in iron deficient anemic mice. Nutr Rep Int 26:861–870, 1982

    Google Scholar 

  74. Kuvibidila SR: Effects of moderate and severe iron deficiency anemia on mitogenic response of lymphocytes from mice spleen and lymph nodes. Acta Pharmacol Toxicol (Suppl)59:122–125, 1985

    Google Scholar 

  75. Blakely BR, Hamilton DL: The effect of iron deficiency on the immune response in mice. Drug Nutr Interact 5(4):249–255, 1988

    Google Scholar 

  76. Dhur A, Galan P, Hannoun C, Hout K, Hercberg S: Effects of iron deficiency upon the antibody response to influenza virus in rats. J Nutr Biochem 1:629–634, 1990

    Google Scholar 

  77. Chandra RK, Newberne PM: Nutrition Immunity and Infections. New York, Plenum, 1977, pp 67–126

    Google Scholar 

  78. Kuvibidila S, Wade S: Macrophage function as studied by the clearance of 125I-labeled polyvinylpyrrolidone in iron-deficient and iron-replete mice. J Nutr 117(1):170–176, 1987

    Google Scholar 

  79. Moore LL, Humbert JR: Neutrophil bactericidal dysfunction towards oxidant radical-sensitive microorganisms during experimental iron deficiency. Pediat Res 18:789–791, 1984

    Google Scholar 

  80. Spear AT, Sherman AR: Iron deficiency alters DMBA-induced tumor burden and natural killer cell cytotoxicity in rats. J Nutrit 122(1):46–55, 1992

    Google Scholar 

  81. Djeha A, Brock JH: Uptake and intracellular handling of iron from transferrin and iron chelates by mitogen stimulated mouse lymphocytes. Biochim Biophys Acta 1133:147–152, 1992

    Google Scholar 

  82. Rudd MJ, Good MF, Chapman DE, Powell LW, Halliday JW: Clonal analysis of the effect of iron on human cytotoxic and proliferating T lymphocytes. Immunol Cell Biol 68:317–324, 1990

    Google Scholar 

  83. Good MR, Powell LW, Halliday JW: The effect of non-transferrin-bound iron on murine T lymphocyte subsets: Analysis by clonal techniques. Clin Exp Immunol 70:164–172, 1987

    Google Scholar 

  84. Djeha A, Brock JH: Effect of transferrin, lactoferrin and chelated iron on human T lymphocytes. Br J Haematol 80(2):235–241, 1992

    Google Scholar 

  85. Nishiya K, de Sousa M, Tsoi E, Bognacki JJ, de Harven E: Regulation of expression of a human lymphoid cell surface marker by iron. Cell Immunol 53:71–83, 1980

    Google Scholar 

  86. Novogrodsky A, Suthanthiran M, Stenzel KH: Immune stimulatory properties of metalloporphyrins. J Immunol 143:3981–3987, 1989

    Google Scholar 

  87. Novogrodsky A, Suthanthiran M, Stenzel KH: Ferromitogens: Iron-containing compounds with lymphocyte-stimulatory properties. Cell Immunol 133:295–305, 1991

    Google Scholar 

  88. Akbar AN, Fitzgerald-Bocarsly PA, de Sousa M, Giardina PJ, Hilgartner MW, Grady RW: Decreased natural killer activity in thalassemia major: A possible consequence of iron overload. J Immunol 136(5):1635–1640, 1986

    Google Scholar 

  89. Kapadia A, de Sousa M, Markenson AL, Miller DR, Miller R, Good RA, Gupta S: Lymphoid cell sets and serum immunoglobulins in patients with thalassemia intermedia: Relationship to serum iron and splenectomy. Br J Haematol 45:405, 1980

    Google Scholar 

  90. Grady RW, Akbar AN, Giardina PJ, Hilgartner MW, de Sousa M: Disproportionate lymphoid cell subsets in thalassemia major: The relative contribution of transfusion and splenectomy. Br J Haematol 59:713, 1985

    Google Scholar 

  91. Abruzzo LV, Rowley DA: Homeostasis of the antibody response: Immunoregulation by NK cells. Science 222:581, 1983

    Google Scholar 

  92. Brieva JA, Stevens RH: Involvement of the transferrin receptor in the production of NK-induced suppression of human antibody synthesis. J Immunol 133:1288, 1984

    Google Scholar 

  93. Dhur A, Galan P, Hercberg S: Iron status, immune capacity and resistance to infections. Comp Biochem Physiol 94A(1):11–19, 1989

    Google Scholar 

  94. Strauss RG: Iron deficiency, infections, and immune function: A reassessment. Am J Clin Nutr 31:660–666, 1978

    Google Scholar 

  95. Hershko C, Peto TEA, Weatherall DJ: Iron and infection. Br Med J 296:660, 1988

    Google Scholar 

  96. Bullen JJ, Ward CG, Rogers HJ: The critical role of iron in some clinical infections. Eur J Clin Microbiol Infect Dis 10(8):613–617, 1991

    Google Scholar 

  97. Weinberg ED: Cellular iron metabolism in health and disease. Drug Metab Rev 22(5):531–579, 1990

    Google Scholar 

  98. Brock JH, de Sousa M: Immunoregulation by iron-binding proteins. Immunol Today 7(2):30, 1986

    Google Scholar 

  99. Dallman PR, Beutler E, Finch CA: Effects of iron deficiency exclusive of anemia. Br J Haematol 40:179–184, 1978

    Google Scholar 

  100. Oski FA: The nonhematologic manifestation of iron deficiency. Am J Dis Child 133:315–322, 1979

    Google Scholar 

  101. Lozoff B, Brittenham GM, Viteri FE, Wold AW, Urrutia J: Developmental deficients in iron-deficient infants: Effects of age and severity of iron lack. J Pediat 101:948–952, 1982

    Google Scholar 

  102. Cook JD, Lynch SR: The liabilities of iron deficiency. Blood 68:803–809, 1986

    Google Scholar 

  103. Sullivan JL: The iron paradigm of ischemic heart disease. Am Heart J 117:1177–1188, 1989

    Google Scholar 

  104. Cathcart MK, McNally AK, Morel DW, Chisolm III GM: Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin. J Immunol 142:1963–1969, 1989

    Google Scholar 

  105. Kochan I: The role of iron in bacterial infections with special consideration of host-tubercle bacillus interaction. Curr Top Microbiol Immunol 60:1–30, 1973

    Google Scholar 

  106. Taylor AE, Matalon S, Ward P (eds): Physiology of Oxygen Radicals. Baltimore, Williams & Wilkins, 1986

    Google Scholar 

  107. Breedveld FC, Dynesius-Trentham R: Collagen arthritis in the rats is initiated by CD4+ T cells and can be amplified by iron. Cell Immunol 121(1):1–12, 1989

    Google Scholar 

  108. Andrews FJ, Morris CJ, Lewis EJ, Blake DR: Effect of nutritional iron deficiency on acute and chronic inflammation. Ann Rheum Dis 46(11):859–865, 1987

    Google Scholar 

  109. Kaplan J, Jordan I, Sturrock A: Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem 266(5):2997–3004, 1991

    Google Scholar 

  110. Seligman PA, Kovar J, Schleicher RB, Gelfand EW: Transferrin-independent iron uptake supports B lymphocyte growth. Blood 78(6):1526–1531, 1991

    Google Scholar 

  111. Alcantara O, Javors M, Boldt DH: Induction of protein kinase C mRNA in cultured lymphoblastoid T cells by iron-transferrin but not by soluble iron. Blood 77(6):1290–1297, 1991

    Google Scholar 

  112. Kuvibidila S, Baliga BS, Murthy KK: Impaired protein kinase C activation as one of the possible mechanisms of reduced lymphocyte proliferation in iron deficiency in mice. Am J Clin Nutr 54(5):944–950, 1991

    Google Scholar 

  113. Brock JH: The role of transferrin in lymphocyte transformation. Haematologia 17(2):187–198, 1984

    Google Scholar 

  114. Kovár J, Franek F: Growth-stimulating effect of transferrin on a hybridoma cell line: Relation to transferrin iron-transporting function. Exp Cell Res 182:358–369, 1989

    Google Scholar 

  115. Manger B, Weiss A, Hardy KJ, Stobo JD: A transferrin receptor antibody represents one signal for the induction of IL2 production by a human T cell line. J Immunol 136(2):532–538, 1986

    Google Scholar 

  116. Cano E, Pizarro A, Redondo JM, Sánchez-Madrid F, Bernabeu C, Fresno M: Induction of T cell activation by monoclonal antibodies specific for the transferrin receptor. Eur J Immunol 20:765–770, 1990

    Google Scholar 

  117. Toole-Simms W, Sun IL, Faulk WP, Löw H, Lindgren A, Crane FL, Morré DJ: Inhibition of transplasma membrane electron transport by monoclonal antibodies to the transferrin receptor. Biochem Biophys Res Comm 176(3):1437–1442, 1991

    Google Scholar 

  118. Bretscher MS: Cells can use their transferrin receptors for locomotion. Embo J 11(2):383–389, 1992

    Google Scholar 

  119. Fargion S, Fracanzani AL, Cislaghi V, Levi S, Cappellini MD, Fiorelli G: Characteristics of the membrane receptor for human H-ferritin. In Biotechnology of Plasma Proteins. Curr Stud Hematol Blood Transf, A Albertini, CL Lenfant, PM Mannucci, JJ Sixma (eds). Basel, Karger, 1991, Vol 58, pp 164–170

    Google Scholar 

  120. Fargion S, Fracanzani AL, Brando B, Arosio P, Levi S, Fiorelli G: Specific binding sites for H-ferritin on human lymphocytes: Modulation during cellular proliferation and potential implication in cell growth control. Blood 78(4):1056–1061, 1991

    Google Scholar 

  121. Broxmeyer HE, Cooper S, Levi S, Arosio P: Mutated recombinant human heavy-chain ferritins and myelosuppressionin vitro andin vivo: A link between ferritin ferroxidase activity and biological function. Proc Natl Acad Sci USA 88:770–774, 1991

    Google Scholar 

  122. Moroz C, Lahat N, Biniaminov M, Ramot G: Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole. Clin Exp Immunol 29:30, 1977

    Google Scholar 

  123. Hann HWL, Stahlhut MW, Chung C: Inhibitory effect of isoferritins from tumor and non-tumor tissues on E-rosette formation. Lancet 1:43, 1984

    Google Scholar 

  124. Ramot B, Biniaminov M, Shohan C, Rosenthal E: Effect of levamisole on E-rosettes forming cellsin vivo andin vitro in Hodgkin's disease. N Engl J Med 294:809, 1976

    Google Scholar 

  125. Moroz C, Kupfer B: Suppressor cell activity of ferritin-bearing lymphocytes in patients with breast cancer. Isr J Med Sci 17:879, 1981

    Google Scholar 

  126. Pattanapanyasat K, Hoy TG, Jacobs A, Courtney S, Webster DJ: Ferritin-bearing T lymphocytes and serum ferritin in patients with breast cancer. Br J Cancer 57:193, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Iowa College of Medicine and VAMC, 52242, Iowa City, Iowa

    John D. Kemp

Authors
  1. John D. Kemp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kemp, J.D. The role of iron and iron binding proteins in lymphocyte physiology and pathology. J Clin Immunol 13, 81–92 (1993). https://doi.org/10.1007/BF00919264

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00919264

Key words

Search

Navigation